2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting ; volume:32 ; number:1 ; day:18 ; month:12 ; year:2023 ; pages:1-7 ; date:1.2024
Supportive care in cancer ; 32, Heft 1 (18.12.2023), 1-7, 1.2024
- Creator
-
Rapoport, Bernardo Leon
Herrstedt, Jørn
Snow, Rebecca Clark
Radhakrishnan, Venkatraman
Saito, Mitsue
Navari, Rudolph M.
Smit, Teresa
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-08224-1
- URN
-
urn:nbn:de:101:1-2024032721101038625555
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rapoport, Bernardo Leon
- Herrstedt, Jørn
- Snow, Rebecca Clark
- Radhakrishnan, Venkatraman
- Saito, Mitsue
- Navari, Rudolph M.
- Smit, Teresa
- SpringerLink (Online service)
Other Objects (12)
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Nausea and vomiting: mechanisms and treatment
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Anticipatory nausea in cyclical vomiting
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Nausea and vomiting: mechanisms and treatment
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Anticipatory nausea in cyclical vomiting
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Nausea and vomiting: mechanisms and treatment
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Anticipatory nausea in cyclical vomiting
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study